Biosynthesis and purification method of Asperparaline A
Through the biosynthesis and purification process of Aspergillus fijiensis YS-1 strain, the existing Asperparaline A extraction and separation process is solved, and the efficient and low-cost Asperparaline A extraction is achieved, which is suitable for industrial production and improves the The yield of active substances.
Patent Information
- Application Number
- CN202411165382.3
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Priority Date
- 2023-08-25
- Filing Date
- 2024-08-23
- Publication Date
- 2024-11-22
AI Technical Summary
The existing Asperparaline A extraction and separation process is complex and costly, making it difficult to be suitable for industrial production.
Biosynthesis and purification were performed using Aspergillus fijiensis YS-1 strain. Through fermentation culture, alcohol solution extraction, column chromatography purification and recrystallization, gradient elution was performed using macroporous resin to optimize the elution conditions to improve efficiency and purity.
It realizes efficient extraction of Asperparaline A, reduces costs, is green and environmentally friendly, is suitable for industrial production, and increases the yield of active substances.
Smart Images

Figure CN118995849A_ABST
Abstract
Description
[Technical field]
[0001] The invention belongs to the application field of microbial source pesticides, relates to a method for biosynthesis and purification of Asperparaline A, and also a method for biosynthesizing Asperparaline A by using Aspergillus Fijiensis YS-1 and performing efficient extraction. [Background technology]
[0002] Asperparaline A is an isopentenyl indole alkaloid containing a [2,2,2]-cyclodiazooctane ring system. It was first reported as a metabolite produced by Aspergillus japonicus JV-23 and has anthelmintic activity against the third-instar larvae of parasitic nematodes in the digestive tract of mammals. Some studies have further found that the substance exhibits insecticidal activity against agricultural pests such as brown planthoppers (International Patent Publication No. 2010 / 071218). In addition, some studies have reported that the substance exhibits insecticidal activity against animal parasitic pests such as hard ticks and fleas, and is safe for mammals (International Patent Publication No. 2010 / 071219). In summary, Asperparaline A has the potential to be used as an insecticide and can be developed as a new microbial pesticide.
[0003] Regarding the preparation process of Asperparaline A, the currently reported method is to soak the raw material (9 kg) fermented by the JV-23 strain in methanol, extract the water concentrate obtained by evaporating the methanol with dichloromethane, and distribute the obtained dichloromethane extract between n-hexane and 90% methanol, and then concentrate the lower layer and extract it with ethyl acetate; the ethyl acetate layer is then dried over anhydrous sodium sulfate, filtered and evaporated to dryness; the residue (3.98 g) is chromatographed on Wakogel C-200, eluted with ethyl acetate and a solution with an increased methanol ratio, and a 25% methanol eluate (600 mg) is obtained; the 25% methanol eluate is further chromatographed on Wakogel C-200 with a chloroform-methanol mixture, and the 5% methanol eluate is recrystallized to obtain Asperparaline A (1204 mg).
[0004] The above-mentioned process of extracting, separating and purifying Asperparaline A using Aspergillus japonicus JV-23 is relatively complicated. The study used a silica gel column for column chromatography separation. The stationary phase and mobile phase used were relatively expensive, making it difficult to carry out actual industrial production. [Summary of the invention]
[0005] In view of the fact that there is no report on artificial total synthesis or semi-synthesis of Asperparaline A in existing research, the present invention provides a method for biosynthesis and purification of Asperparaline A, which is a biosynthesis method for quickly and efficiently extracting Asperparaline A from Aspergillus fijiensis YS-1. The method comprises the steps of culturing and collecting YS-1, extracting, separating and purifying metabolites, identifying structures and the like. Purifying Asperparaline A through biosynthesis has the advantages of high efficiency, low cost, green environmental protection, easy operation, easy scale-up and the like.
[0006] During a field investigation in Yangshuo County, Guilin City, the inventor discovered dead adult citrus psyllids, and isolated multiple fungi from the corpses. One of them was identified as Aspergillus fijiensis, named AspergillusfijiensisYS-1, and was preserved in the Guangdong Provincial Microbiological Culture Collection Center on July 7, 2020, with the preservation number GDMCCNo.61081.
[0007] The technical solution of the present invention is as follows:
[0008] A method for biosynthesis and purification of Asperparaline A, comprising the following steps:
[0009] S1. Fermentation culture: Fermentation culture of Aspergillus fijiensis YS-1 strain to obtain fungal spores;
[0010] S2. Extraction of active ingredients: Aspergillus fijiensis YS-1 spores were extracted by alcohol solution and concentrated to obtain an extract;
[0011] S3. Column chromatography purification and separation: The extract is dispersed and dissolved in water, subjected to column chromatography gradient elution, and the specific eluents are collected, combined and concentrated to obtain a concentrated eluent;
[0012] S4. Refining: Let the concentrated eluate stand for recrystallization and filter the mother liquor. The resulting crystals are Asperparaline A.
[0013] In step S1, the Aspergillus fijiensis YS-1 strain is a fungus isolated from the dead corpses of adult citrus psyllids in the field in Yangshuo County, Guilin City. One of the strains was identified as Aspergillus fijiensis, named Aspergillus fijiensis YS-1, and was preserved in the Guangdong Provincial Microbiological Culture Collection Center on July 7, 2020. The preservation address is: 5th Floor, Building 59, No. 100 Xianlie Middle Road, Guangzhou City, and the preservation number is GDMCC No. 61081.
[0014] In step S1, potato dextrose agar medium (PDA) or other solid culture medium is selected for indoor fermentation culture, the culture time is 3-15 days, and the culture temperature is 20-38°C.
[0015] In step S2, a methanol or ethanol solution with a volume fraction of 30-95% is used, and a solid-liquid ratio (g:mL) is 1:10-1:40.
[0016] In step S2, the extraction method includes ultrasonic assisted extraction, microwave assisted extraction, heating reflux extraction, and two-phase aqueous extraction.
[0017] In step S2, if ultrasonic-assisted extraction is used, the preferred conditions are as follows: 100-300 g of YS-1 spore material is placed in a conical flask, 1000-6000 mL of a 30-95% methanol solution is added thereto, ultrasonic extraction is performed at 30-80° C. for 30-90 min, power is 200-800 W, frequency is 20-80 KHz, the extraction is repeated 2-5 times, and then the solvent is removed by negative pressure distillation to obtain an extract.
[0018] In step S3, the mass (g) of the extract is weighed, and 5-20 times the volume (mL) of pure water is added to dissolve and disperse the extract, and then the extract is loaded onto the column by wet method.
[0019] In step S3, the macroporous resin is selected from other macroporous resins such as D101, AB-8, LX-8 or LSA-7.
[0020] In step S3, if D101 macroporous resin is used as the stationary phase, the preferred elution conditions are: elution with ethanol solutions with volume fractions of 15%, 25%, 30%, and 40% in sequence, each gradient elution volume is 1.0-10.0BV, the flow rate is controlled at 0.5-5.0BV / h, and the eluates with 30% and 40% ethanol are collected and concentrated and combined.
[0021] In step S4, the purification method includes crystallization, precipitation, membrane separation, preparative liquid chromatography, silica gel column chromatography or ODS column chromatography.
[0022] In step S4, the concentrated eluate is allowed to stand to wait for natural crystal precipitation, and the target active ingredient Asperparaline A is obtained after filtering out the mother liquor.
[0023] More specifically,
[0024] The method for biosynthesis and purification of Asperparaline A described in the present invention is a method for biosynthesizing and purifying Asperparaline A using Aspergillus fijiensis YS-1, comprising the following steps:
[0025] S1: Acquisition of Aspergillus Fijiensis YS-1:
[0026] Dead citrus psyllid adults were found in the fields of Yangshuo County, Guilin City. Several fungi were isolated from the dead insects, one of which was identified as Aspergillus fijiensis and named Aspergillus fijiensis YS-1.
[0027] S2: Cultivation and spore collection of Aspergillus Fijiensis YS-1:
[0028] The Aspergillus fijiensis YS-1 spores from the citrus psyllid were inoculated on 2000 PDA culture media, and after continuous cultivation in the room for 7 days, the Aspergillus fijiensis YS-1 spores were shaken off into a conical flask to obtain spores with strong infectivity.
[0029] S3: Extraction of secondary metabolites from Aspergillus Fijiensis YS-1:
[0030] Weigh 150g of the YS-1 spore material obtained in the previous step, add 4L of 85% methanol by volume, divide into 4 portions in a conical flask, perform ultrasonic extraction at 50°C for 60min, repeat the extraction three times, and then remove the solvent by negative pressure distillation. After combining, 50.0g of extract is obtained, and 500ml of pure water is added to dissolve and disperse to obtain a concentrated solution;
[0031] S4: Purification and extraction of Asperparaline A:
[0032] S4-1: Macroporous resin pretreatment:
[0033] Prepare 5.0L of newly purchased macroporous resin, add 95% ethanol to it, let it stand for 24 hours, then add it to an empty chromatography column, wait for it to settle naturally, then use ethanol to pass through the resin layer at a flow rate of 2.0BV / h, wash until the effluent is free of white turbidity, then replace the ethanol with distilled water, rinse until the effluent has no alcohol taste; then use 2.0BV 5% (v / v) HCl solution to pass through the resin layer at a flow rate of 4.0-6.0BV / h, and soak for 2-4 hours, then use water to wash at the same flow rate until the pH of the effluent is neutral, then use 2.0BV of 2.0% (w / v) NaOH solution to pass through the resin layer at a flow rate of 4.0-6.0BV / h, and soak for 2-4 hours, then wash with water at the same flow rate until the pH of the effluent is neutral;
[0034] S4-2: Selection of macroporous resin and optimization of elution conditions:
[0035] The 85% (v / v) methanol solution extract (concentrate) of Aspergillus fijiensis YS-1 was separated by chromatography on pretreated D101, AB-8, LX-8 and LSA-7 macroporous resin columns respectively, and the column was wet loaded, and pure water, 20%, 40%, 60%, 80% and 95% ethanol solutions were used as mobile phases for separation and elution, and the macroporous resins were screened according to the biological activity of the eluents; the macroporous resin eluents with similar chromatograms were combined according to the analysis results of HPLC, and the ethanol ratio of the eluents was further optimized;
[0036] S4-3: Separation and purification:
[0037] The concentrated solution obtained from S3 was slowly drained into the macroporous resin chromatography column with a glass rod. After the sample was added, it was allowed to stand for 30 minutes to allow the sample to be fully adsorbed on the macroporous resin; gradient elution was performed with 15%, 25%, 30%, and 40% ethanol solutions by volume fractions in sequence, and finally the chromatography column was rinsed with 95% ethanol solution. The volume of each gradient elution was 1.0 BV, and the flow rate was controlled to be 2.0 BV / h. The eluate of 30% and 40% ethanol solution was collected by equal flow fraction method (1L), and concentrated under reduced pressure by rotary evaporator. The concentrated solution was combined and allowed to stand overnight at 4°C to wait for the crystals to precipitate automatically. The chromatography column rinsed with 95% ethanol solution can be reused.
[0038] S5: Purity test and structural identification of Asperparaline A extract:
[0039] S5-1: HPLC purity test of Asperparaline A:
[0040] Instrument model: Shimadzu LC-20A;
[0041] Chromatographic column: inertsil ods-3 (4.6 mm id × 250 mm, 5 μm);
[0042] Mobile phase: water (phase A), methanol (phase B);
[0043] Gradient program: 0-25 min, B%: 5-100%;
[0044] Flow rate: 1 mL min -1 ;
[0045] Column temperature: 35°C;
[0046] Injection volume: 5.0 μL;
[0047] Wavelength: 206nm.
[0048] S5-2: Asperparaline A structure identification:
[0049] The extracted and purified Asperparaline A was analyzed by single crystal X-ray diffraction, nuclear magnetic resonance (NMR) and high resolution mass spectrometry (HR-MS), and compared with the literature and Pubchem database to clarify its structure.
[0050] In the present invention:
[0051] The selection of the macroporous resin and the optimization of the elution conditions described in step S4-2 are preferably D101 macroporous resin. Experiments have shown that D101 macroporous resin has good selectivity for crude extracts, and the biological activity of the 40% (v / v) ethanol eluate is significantly higher than that of the eluates of other macroporous resins at various ratios (see Figure 1 ), which can effectively enrich the active ingredients of Aspergillus fijiensis YS-1, merge the D101 eluates with similar chromatograms according to the HPLC analysis results, and further optimize the ethanol ratio of the eluates.
[0052] Compared with the prior art, the present invention has the following advantages:
[0053] 1. The method for biosynthesis and purification of Asperparaline A described in the present invention is highly efficient. 121 mg of the target compound can be extracted from every 150 g of fungal spores. After extraction, high-purity crystals can be naturally precipitated through simple column chromatography and concentration, eliminating complicated steps such as extraction.
[0054] 2. The method for biosynthesis and purification of Asperparaline A described in the present invention has low cost. The solvents used for extraction and purification are mainly water, ethanol, methanol, and macroporous resin, which are all common bulk chemical products and have low cost.
[0055] 3. The method for biosynthesis and purification of Asperparaline A described in the present invention is pollution-free. The solvent used to extract the active ingredient can be reused after distillation. The stationary phase and mobile phase of the chromatography column can also be reused after treatment. The whole process is green and environmentally friendly.
[0056] 4. The method for biosynthesis and purification of Asperparaline A described in the present invention is suitable for microbial fermentation process. In actual production, when a macroporous resin is used to treat microbial secondary metabolites, the resin can be added to the fermentation liquid during the liquid fermentation stage. The macroporous resin will adsorb the target product and promote the biosynthesis reaction to produce the target product. This method can effectively reduce the feedback inhibition phenomenon in the fermentation process and greatly increase the yield of active substances.
Brief Description of the Drawings
[0057] Figure 1 Gradient elution chromatograms of various types of macroporous resins in the embodiments of the present invention (A. D101 macroporous resin; B. AB-8 macroporous resin; C. LX-8 macroporous resin; D. LSA-7 macroporous resin. The Y axis is the HPLC chromatogram of the eluent obtained by eluting with water, 20%, 40%, 60%, 80%, and 95% ethanol in sequence, the X axis is the retention time RT (min) of each substance, and the Z axis represents the response intensity Intensity (μV));
[0058] Figure 2 HPLC chromatograms of 15%, 25%, 30%, and 40% ethanol elution concentrates of D101 macroporous resin in the embodiment of the present invention;
[0059] Figure 3 Graph showing the insecticidal activity of each eluate of D101 against citrus psyllid in the examples of the present invention (abscissas 1, 2, 3, and 4 are 15%, 25%, 30%, and 40% ethanol eluates);
[0060] Figure 4 It is the HPLC chromatogram of Asperparaline A in the embodiment of the present invention;
[0061] Figure 5 A diagram showing the molecular structure of Asperparaline A in an embodiment of the present invention;
[0062] Figure 6 HR-ESI-MS[M+H] of Asperparaline A in the embodiment of the present invention + Mass spectra;
[0063] Figure 7This is an ORTEP diagram of the single crystal structure of Asperparaline A in an embodiment of the present invention;
[0064] Figure 8 is Asperparaline A in the embodiment of the present invention 13 C NMR (600 MHz, Pyridine-d 5 ) spectrum;
[0065] Fig. 9 is Asperparaline A in the embodiment of the present invention 1 H NMR (600 MHz, Pyridine-d 5 ) spectrum. [Specific implementation method]
[0066] The specific implementation modes of the present invention are further described below in conjunction with examples.
[0067] Example:
[0068] 1. Brief description:
[0069] This study provides a method for biosynthesizing Asperparaline A by Aspergillus Fiji YS-1 and its rapid and efficient extraction, which includes the steps of culturing and collecting YS-1, extracting, separating and purifying metabolites, and identifying their structures.
[0070] 2. Cultivation and spore collection of Aspergillus Fijiensis YS-1:
[0071] The Aspergillus fijiensis YS-1 spores from the citrus psyllid were inoculated onto 2000 PDA culture media respectively. After continuous cultivation indoors for 7 days, the Aspergillus fijiensis YS-1 spores were shaken off into a conical flask to obtain spores with strong infectivity.
[0072] 3. Extraction of secondary metabolites of Aspergillus Fiji YS-1:
[0073] Weigh 150g of YS-1 spore raw material, add 4L of 85% methanol, divide it into 4 parts in a conical flask, and extract it ultrasonically at 50°C for 60min. Repeat the extraction three times, and then remove the solvent by negative pressure distillation. After combining, 50.0g of extract is obtained, which is dissolved and dispersed in 500ml of pure water to obtain a concentrated solution.
[0074] 4. Purification and extraction of Asperparaline A:
[0075] 4.1 Macroporous resin pretreatment:
[0076] Prepare about 5.0L of newly purchased macroporous resin, add 95% ethanol to it, let it stand for 24 hours, and then add it to an empty chromatography column; after it is naturally precipitated, use ethanol to pass through the resin layer at a flow rate of 2.0BV / h, wash until the effluent is free of white turbidity, then replace the ethanol with distilled water, and rinse until the effluent has no alcohol taste; then use 2.0BV of 5% HCl solution to pass through the resin layer at a flow rate of 4.0-6.0BV / h, and soak for 2-4 hours, and then use water to wash at the same flow rate until the pH of the effluent is neutral; then use 2.0BV of 2.0% NaOH solution to pass through the resin layer at a flow rate of 4.0-6.0BV / h, and soak for 2-4 hours, and then wash with water at the same flow rate until the pH of the effluent is neutral;
[0077] 4.2 Selection of macroporous resin and optimization of elution conditions:
[0078] The 85% methanol solution extract of YS-1 was separated by chromatography on pretreated D101, AB-8, LX-8, and LSA-7 macroporous resin columns, and wet-packed, and separated and eluted with pure water, 20%, 40%, 60%, 80%, and 95% ethanol solutions as mobile phases, and the appropriate macroporous resin was selected according to the biological activity of the eluent.
[0079] The experiment found that D101 macroporous resin had good selectivity for crude extracts, and the biological activity of 40% ethanol eluent was significantly higher than that of eluents of other macroporous resins at various ratios (see Figure 1 ), which can effectively enrich the active ingredients of YS-1, merge the D101 eluates with similar chromatograms according to the HPLC analysis results, and further optimize the ethanol ratio of the eluates;
[0080] The HPLC detection of the macroporous resin eluate is as follows:
[0081] Instrument model: Shimadzu LC-20A;
[0082] Chromatographic column: inertsil ods-3 (4.6mm id×250mm, 5μm);
[0083] Mobile phase: water (phase A), methanol (phase B);
[0084] Gradient program: 0-25 min, B%: 5-100%;
[0085] Flow rate: 1 mL min -1 ;
[0086] Column temperature: 35°C;
[0087] Injection volume: 5.0 μL;
[0088] Wavelength: 254nm;
[0089] 4.3 Separation and purification:
[0090] The concentrated solution obtained in step 3 was slowly drained into the macroporous resin chromatography column with a glass rod. After the sample was added, it was allowed to stand for 30 minutes to allow the sample to be fully adsorbed on the macroporous resin; gradient elution was performed with 15%, 25%, 30%, and 40% ethanol solutions in turn, and finally the chromatography column was rinsed with 95% ethanol solution. The volume of each gradient elution was 1.0 BV, and the flow rate was controlled to be 2.0 BV / h. The equal flow method (1L) was used for collection, and the eluate was collected in sequence and numbered, and finally concentrated under reduced pressure by a rotary evaporator; the concentrated solution was placed at 4°C and allowed to stand overnight to wait for the automatic precipitation of crystals. Single crystals were selected for HPLC, X-ray single crystal diffraction, nuclear magnetic resonance, and high-resolution mass spectrometry analysis.
[0091] 5. HPLC detection of purified compounds:
[0092] Instrument model: Shimadzu LC-20A;
[0093] Chromatographic column: inertsil ods-3 (4.6mm id×250mm, 5μm);
[0094] Mobile phase: water (phase A), methanol (phase B);
[0095] Gradient program: 0-25 min, B%: 5-100%;
[0096] Flow rate: 1 mL min -1 ;
[0097] Column temperature: 35°C;
[0098] Injection volume: 5.0 μL;
[0099] Wavelength: 206nm;
[0100] 6. Compound structure identification:
[0101] The compound structures were analyzed by X-ray single crystal diffraction, nuclear magnetic resonance (NMR) and high-resolution mass spectrometry (HR-MS), and compared with the literature and Pubchem database;
[0102] 7. Experimental results:
[0103] 5.1 Screening results of different types of macroporous resins:
[0104] Four different types of macroporous resins, D101, AB-8, LX-8, and LSA-7, were selected to perform preliminary separation of the extract of Aspergillus Fiji YS-1. Gradient elution was performed using ethanol solutions with a volume ratio of 0, 20, 40, 60, 80, and 95%, and the biological activity of each eluent was evaluated by indoor insecticidal activity. The results showed that the separation effect of the eluents with different ratios of D101 macroporous resin was better, and the HPLC response value was higher (see Figure 1 ); The results of the indoor toxicity experiment (see Table 1) showed that the 40% eluate of D101 macroporous resin had a good lethal effect on citrus psyllids.
[0105] Table 1 Insecticidal activity of components against citrus psyllids after gradient elution separation using different types of macroporous resin columns
[0106]
[0107] Note: Components 1, 2, 3, 4, and 5 are the concentrates obtained by combining water, 20%, 40%, 60%, and 80% ethanol eluates (a total of 250 mL); the results shown in the table are the mean ± standard error of the mortality rate of the test insects; the insecticidal activity of different components against citrus psyllids was significantly different using one-way ANOVA (Tukey's HSD test, p<0.05, represented by lowercase letters); the data shown are the mean ± SEM of mortality rate.
[0108] 5.2Optimization of elution conditions of D101 macroporous resin:
[0109] On the basis of "5.1", D101 macroporous resin was selected as the separation resin of the effective component of YS-1, and the elution conditions of D101 macroporous resin were further optimized; the volume ratio of ethanol was set to 15, 25, 30, and 40% for gradient elution, and the insecticidal activity of different eluents was evaluated by HPLC and indoor bioassay. HPLC analysis showed that: the D101 eluent with 30% ethanol had an obvious chromatographic peak at 22.5min (see Figure 2 ), indicating that the eluent contains a single major compound other than the solvent itself; the HPLC chromatogram of the eluent of D101 with 40% ethanol is similar to the above, but with a lower peak height (see Figure 2 ), indicating that the eluate contains a single compound other than the solvent itself, and that the compound is the same substance as the compound in the 40% ethanol D101 eluate. The mortality rate of citrus psyllids treated with 30% eluate for 72 hours was 63.37%, and that after treatment with 40% eluate was 24.16%, indicating that the 30% and 40% ethanol eluates have significant insecticidal activity against citrus psyllids (see Figure 3 ).
[0110] 5.3 Preparation of Asperparaline A:
[0111] The 30% and 40% ethanol eluates of D101 macroporous resin were concentrated and combined, and allowed to stand overnight at 4°C to allow crystals to precipitate automatically. A total of 121 mg was obtained after filtration. A small amount of crystals was taken and dissolved in pure water and analyzed by HPLC. The chromatogram is shown in the figure below. Figure 4 As shown, the results show that the retention time of the substance (black arrow) is 22.5min, which is consistent with the retention time of the main components of the 30% and 40% ethanol eluents. After integration, the peak area of the chromatographic peak exceeds 95% in the spectrum.
[0112] 5.4Verification of Asperparaline A Molecular Structure:
[0113] X-ray single crystal diffraction, nuclear magnetic resonance and high-resolution mass spectrometry were used for analysis, and the structure of the substance was verified by referring to the Pubchem database and relevant literature data.
[0114] The results showed that the crystals precipitated in "5.3" were the compound Asperparaline A, whose molecular structure is as follows Figure 5 As shown, its HR-ESI-MS[M+H] + Mass spectra such as Figure 6 As shown, its single crystal structure ORTEP diagram is as follows Figure 7 As shown, its 13 C NMR (600 MHz, Pyridine-d 5 ) spectrum as Figure 8 As shown, its 1 H NMR (600 MHz, Pyridine-d 5 ) spectrum as Fig. 9 shown.
[0115] The above description is only a preferred embodiment of the present invention. It should be pointed out that, for ordinary technicians in this field, without departing from the creative concept of the present invention, several improvements and changes can be made, which all belong to the protection scope of the present invention.
Claims
1. A method for biosynthesis and purification of Asperparaline A, characterized in that: The following steps are involved: S1. Fermentation culture: Fermentation culture of Aspergillus fijiensis YS-1 strain to obtain fungal spores; The Aspergillus fijiensis YS-1 strain is a fungus isolated from the dead bodies of adult citrus psyllids in the field in Yangshuo County, Guilin City. One of the strains was identified as Aspergillus fijiensis, named Aspergillus fijiensis YS-1, and was preserved in the Guangdong Provincial Microbiological Culture Collection Center on July 7, 2020. The preservation address is: 5th Floor, Building 59, No. 100 Xianlie Middle Road, Guangzhou City, and the preservation number is GDMCC No. 61081; S2. Extraction of active ingredients: using a methanol or ethanol solution with a volume fraction of 30-95%, a solid-liquid ratio of g:mL of 1:10-1:40, extracting Aspergillus fijiensis YS-1 spores by an alcohol solution, and concentrating to obtain an extract; S3. Column chromatography purification and separation: dispersing and dissolving the extract in water, performing column chromatography gradient elution, collecting, combining and concentrating the specific eluent to obtain a concentrated eluent; S4. Refining: Let the concentrated eluate stand for recrystallization and filter the mother liquor. The resulting crystals are Asperparaline A.
2. The method for biosynthesis and purification of Asperparaline A according to claim 1, characterized in that: In step S1, the fermentation culture is carried out indoors using potato dextrose agar medium, the culture time is 3-15 days, and the culture temperature is 20-38°C.
3. The method for biosynthesis and purification of Asperparaline A according to claim 1, characterized in that: In step S2, the extraction method includes ultrasonic-assisted extraction, microwave-assisted extraction, heating reflux extraction, and two-phase aqueous extraction.
4. The method for biosynthesis and purification of Asperparaline A according to claim 3, characterized in that: In step S2, ultrasonic-assisted extraction is used under the following conditions: 100-300 g of YS-1 spore raw material is placed in a conical flask, 1000-6000 mL of a 30-95% methanol solution is added thereto, ultrasonic extraction is performed at 30-80° C. for 30-90 min, power is 200-800 W, frequency is 20-80 KHz, the extraction is repeated 2-5 times, and then the solvent is removed by negative pressure distillation to obtain an extract.
5. The method for biosynthesis and purification of Asperparaline A according to claim 1, characterized in that: In step S3, weigh the mass of the extract (g), add 5-20 times volume mL of pure water to dissolve and disperse it, and wait for wet column loading.
6. The method for biosynthesis and purification of Asperparaline A according to claim 1, characterized in that: In step S3, the macroporous resin is selected from one of D101, AB-8, LX-8 or LSA-7.
7. The method for biosynthesis and purification of Asperparaline A according to claim 6, characterized in that: In step S3, if D101 macroporous resin is used as the stationary phase, the elution conditions are: elution is carried out with ethanol solutions with volume fractions of 15%, 25%, 30%, and 40% in sequence, each gradient elution volume is 1.0-10.0BV, the flow rate is controlled at 0.5-5.0BV / h, and the eluates of 30% and 40% ethanol are collected and concentrated and combined.
8. The method for biosynthesis and purification of Asperparaline A according to claim 1, characterized in that: In step S4, the purification method includes crystallization, precipitation, membrane separation, preparative liquid chromatography, silica gel column chromatography or ODS column chromatography.
9. The method for biosynthesis and purification of Asperparaline A according to claim 1, characterized in that: In step S4, the recrystallization is replaced by waiting for natural precipitation crystallization process.
Citation Information
Patent Citations
Composition to control harmful organisms that contains 16-keto aspergillimide
WO2010071218A1
16-ketoaspergillimide and pest exterminating agent comprising the same as active ingredient
WO2010071219A1
Cited By
Column chromatography and rotary evaporation system and control method, equipment and medium thereof
CN120550450A
Column chromatography and rotary evaporation system, control method, apparatus and medium thereof
CN120550450B
